Lisa Kern, MD, MPH
lisakernmd.bsky.social
Lisa Kern, MD, MPH
@lisakernmd.bsky.social
Associate Professor of Medicine. Health services researcher. @Weill Cornell Medicine
Reposted by Lisa Kern, MD, MPH
99% of new medicines developed by the pharmaceutical industry depend on NIH research jamanetwork.com/journals/jam...
Comparison of Research Spending on New Drug Approvals by the NIH vs the Pharmaceutical Industry
This cross-sectional study examines National Institutes of Health and pharmaceutical industry investments in recent drug approvals.
jamanetwork.com
March 10, 2025 at 2:15 PM
Reposted by Lisa Kern, MD, MPH
Massive NIH cuts to research infrastructure threaten the foundation of U.S. research—putting our future at risk. We need innovation in funding, not dismantling our research engine. My take in @statnews: www.statnews.com/2025/02/08/n...
The NIH’s drastic cut to indirect cost rates is a critical threat to U.S. research infrastructure
The drastic reduction in indirect costs is not a path to innovation or cost savings — it’s a threat to U.S.’s position as global leader in medical research.
www.statnews.com
February 8, 2025 at 4:50 PM
Reposted by Lisa Kern, MD, MPH
An explainer about how health research funding happens and why this NIH funding cycle shutdown matters: www.msnbc.com/opinion/msnb...
Opinion | I’m a health researcher. NIH’s pause on research grants could have a devastating cost.
This is a potentially devastating event — not just for the scientific community, but for all Americans.
www.msnbc.com
January 24, 2025 at 11:39 PM
Reposted by Lisa Kern, MD, MPH
All NIH study sections canceled indefinitely. This will halt science and devastate research budgets in universities.
January 22, 2025 at 8:46 PM